Friday 6 November 2026
Export IRTC’s income statement to Excel — free account
iRhythm Holdings, Inc.
IRTC Healthcare Medical Devices
iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.
- Revenue
- +14.9%
- EPS
- −462.5%
- Free cash flow
- −157.6%
- Total debt
- +0.48%
Quarter to September 2026, against a year earlier
90.26
39.93
−30.67%
Follow IRTC
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 5 |
+8 more TTM periods Free account |
| (25.81%) | (9.63%) | (22.42%) | (36.57%) | ||
| (3.70%) | (1.36%) | (2.88%) | (4.57%) | ||
ROIC |
(11.42%) | (6.32%) | (9.79%) | (16.42%) | |
Return on Tangible Assets |
(5.49%) | (1.92%) | (3.94%) | (6.34%) | |
Average Days of Receivables |
34.67 | 37.27 | 37.46 | 36.98 | |
Free Cash Flow per Share |
0.22 | 1.18 | 0.58 | 1.08 | |
Free Cash Flow |
7.38 | 38.98 | 18.75 | 34.52 | |
Capital Expenditures |
(48.18) | (47.02) | (43.83) | (46.34) | |
| Other line items | |||||
Cash ROIC |
0.53% | 2.73% | 1.38% | 2.49% | |
Accounts Receivable Turnover |
10.86 | 9.92 | 9.76 | 9.60 | |
Accounts Payable Turnover |
20.02 | 15.61 | 22.28 | 46.40 | |
Inventory Turnover |
11.08 | 11.52 | 11.98 | 12.33 | |
Average Days of Payables |
23.72 | 26.97 | 13.67 | 3.74 | |
Days of Inventory on Hand |
35.77 | 34.88 | 38.02 | 35.91 | |
Tax Rate |
0.00 | 0.00 | 0.03 | 0.02 | |
Research and Development Expense of Revenue |
9.89% | 10.29% | 11.10% | 11.73% | |
Selling, General and Administrative Expense of Revenue |
60.32% | 62.25% | 64.54% | 65.93% | |
Share Based Compensation of Revenue |
9.62% | 10.13% | 10.97% | 11.82% | |
Interest Coverage |
(3.71) | (1.89) | (3.12) | (4.36) | |
Operating CF/Net income |
(1.44) | (6.17) | (2.25) | (1.82) | |
Depreciation/Fixed assets |
0.00 | 0.16 | 0.17 | 0.17 | |
Capex/Depreciation |
0.00 | (1.78) | (1.67) | (1.75) | |
Revenue per Share |
25.80 | 25.09 | 24.24 | 23.35 | |
Operating CF per Share |
1.68 | 2.61 | 1.93 | 2.53 | |
Capex per Share |
(1.46) | (1.43) | (1.35) | (1.45) | |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.06 |
Columns are period end dates · fundamentals updated 5 Nov 2026